Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 165

Emailed: 0

PDF Downloaded: 272


Chittaragi, Ambali, Honnutagi, and Ganesh: Role of urinary nephrin to predict early onset of nephropathy in patients with type 2 diabetes mellitus


Introduction

The Type 2 Diabetes Mellitus (T2DM) considered as a metabolic disorder caused by insulin resistance (IR).1 The incidence of T2DM throughout the world, 469 million people million people were affected in 2019 and it will raise up to 2019 700 million by 2045. 2 In indian scenario 77 million people living with T2DM by 2019 and expected to reach 135 million by 2045. 3 Several metabolic changes occur in T2DM patient’s results complications majorly on kidney.Hyperglycemia in patients with T2DM results production of free radicals results damage of kidney lead to diabetic kidney disease (DKD). 4

The DKD is common most complication in patients with T2DM characterised by albuminuria.Microalbumin is considered as earliest clinical available for diabetic nephropathy. According to Kidney Disease Improvement Global Outcome (KDIGO) criteria the microalbuminuria is < 30 mg/g creatinine considered as normoalbuminuria, 30 – 299 mg/g creatinine considered as microalbuminuria and >300 mg/g creatinine considered as macroalbuminuria. 5, 6 But a recent study was reported microalbumin is not a sensitive and specific biomarker for diagnosis and progression of diabetic nephropathy. Since it has a lot of flaws including blood sugar levels, glycated haemoglobin, hypertension, arginine, vasopressin, atrial natriuretic peptide and also the T2DM patients with normoalbuminuria only showed an advanced pathological events without microalbuminuria. 7, 8, 9 Hence there is a need best marker for diabetic nephropathy.

According to recent research studies are reported that podocyte proteins measurement can be used as early diagnosis and prognosis of diabetic nephropathy. 10 The nephrin one of the transmembrane podocyte protein forms the slit diaphragm and it act like a cytoskeleton of maintenance of glycocalyx of glomerular basement membrane prevent the excretion of protein in urine. 11, 12, 13 In T2DM patients due to the metabolic derangements glomerular damage will occur that leading to nephrinuria before appearance of microalbumin. 14, 15, 16 Recent experimental researchers observed significantly increased in T2DM patients with normoalbuminuria without microalbumin and also they suggested that to determination of nephrin in urine use for early clinical marker for diabetic nephropathy. 17, 18, 19 Based on this background, the current study evaluates the correlation of between urinary nephrin and microalbumin in type 2 diabetes mellitus patients.

Materials and Methods

The present study conducted in department of general medicine and collaborated with biochemistry in Sri BM Patil Medical College Hospital and Research Centre, Karnataka, India from 2018-2023. As per American Diabetes Association Criteria (ADA) 60T2DM patientswas recruited and these patients were separated to two subgroups with their microalbumin levels (Microalbumin: < 30 Mg/g Creatinine considered as Group 2: T2DM with normoalbuminuria and Microalbumin: 30-299 Mg/g Creatinine considered as Group 3: T2DM with microalbuminuria) according to KDIGO criteria. Along with that we also recruited 30 age, gender and BMI matched healthy controls and considered as Group 1. All the study subjects included were included after obtaining the institutional ethics committee approval and taken consent from the all individuals.

Inclusion criteria

The study participants age should be 30-70 years without any illness consider as controls. For T2DM diagnosed according to ADA criteria and KDIGO criteria.

Exclusion criteria

The subjects with pregnancy, h/o smoking and alcoholism, other types of diabetes mellitus, hypertension, thyroid diseases, liver diseases, kidney diseases, cardiovascular diseases, vascular diseases, infectious diseases, cerebro vascular diseases were excluded from the study.

Sample collection

Five (5) millilitres (ml) 8 to 12 hours overnight fasting venous blood sample was collected from all the study participants, later 2 ml were transferred to anti-coagulant and anti-glycolytic (Sodium Fluoride) tube and remaining 3 ml transferred to clot activator tube. Second time another 2 ml of blood sample was collected after 2 hours of breakfast. All the samples was separated by the process of centrifugation at 5000 rotation per minute and plasma, serum transferred to bullet vailes and stored until analysis was done. Urine also obtained from all the participants, processed centrifugation and immediately microalbumin was analysed and separated 1 ml of urine into properly labelled aliquots for nephrin.

Statistical analysis

The distribution of data was tested by using kolmogorov smrinov test and expressed normally distributed data into mean ± standard deviation (SD). Analysis of Variance followed by posthoc analysis was done for comparison of variables between the groups. The pearsons correlation analysis was done to correlate between the parameters. Statistical analysis was done by SPSS and P value is < 0.05 was considered significant.

Results

Table 1

Distribution of demographic, anthropometric, biochemical andexperimental parameters between cases and controls

Parameters

Healthy Controls

Patients with T2DM

P- Values

Age (Years)

52.40

±

7.00

53.62

±

6.61

0.63 †

Height (CM)

163.27

±

4.76

165.43

±

5.37

0.04*

Weight (Kg)

57.50

±

3.67

88.02

±

9.60

0.001**

BMI (Kg/m2)

21.58

±

1.18

32.09

±

2.36

0.001**

FBS (Mg/dl)

92.27

±

1.60

160.65

±

10.60

0.001**

PPBS (Mg/dl)

124.60

±

8.08

316.02

±

51.97

0.001**

S. Urea (Mg/dl)

29.97

±

3.65

60.50

±

32.07

0.001**

S. Creatinine (Mg/dl)

0.61

±

0.19

3.65

±

1.59

0.001**

S. Uric Acid (Mg/dl)

4.61

±

0.44

8.02

±

3.50

0.001**

Microalbumin (Mg/g creatinine)

7.26

±

1.27

40.94

±

35.62

0.001**

Urinary Nephrin (ng/ml)

5.11

±

1.34

40.12

±

11.81

0.001**

The height shows moderate significance (P=0.04*) and the weight, body mass index, fasting blood sugars, post parandial blood sugars, urea, creatinine. Uric acid, microalbumin and urinary nephrin was shown significantly very high (P=0.001**) and the age not shown any significance (P=0.63) between healthy controls and T2DM patients.

Table 2

Comparison of anthropometric, biochemical andexperimental parameters between cases and controls by ANOVA.

Parameter

Healthy Controls

T2DM with Normoalbuminuria

T2DM with Microalbuminuria

P – Value

Age (Y)

51.04

±

7.00

53.53

±

6.65

53.70

±

6.68

0.72 †

Height (CM)

163.27

±

4.76

164.20

±

4.69

166.67

±

5.79

0.03*

Weight (Kg)

57.50

±

3.67

84.43

±

8.63

91.60

±

9.31

0.001**

BMI (Kg/m2)

21.58

±

1.18

31.26

±

2.22

32.92

±

2.23

0.001**

FBS (Mg/dl)

92.27

±

1.60

151.37

±

1.99

169.93

±

6.80

0.001**

PPBS (Mg/dl)

124.60

±

8.08

276.27

±

19.73

355.77

±

42.84

0.001**

S. Urea (Mg/dl)

29.97

±

3.65

29.40

±

2.13

91.60

±

9.31

0.001**

S. Creatinine (Mg/dl)

1.24

±

0.19

1.16

±

0.22

8.14

±

0.99

0.001**

S. Uric Acid (Mg/dl)

4.61

±

0.44

4.78

±

1.22

11.26

±

1.28

0.001**

Microalbumin (Mg/g creatinine)

7.26

±

1.27

8.14

±

1.10

73.73

±

18.82

0.001**

Urinary Nephrin (ng/ml)

5.11

±

1.34

29.07

±

2.88

51.18

±

4.74

0.001**

We observed that in anthropometric parameters the weight, BMI showed high significant (P = 0.001**) and height shown moderate significant(P = 0.03*) between the study groups. Along with the fasting blood sugars, post parandial blood sugars, urea, creatinine, uric acid and microalbumin shown very high significant (P=0.001**). The nephrin also shown a highly significance between the both the study groups (P= 0.001**) (Table 2).

Table 3

Comparision of biochemical variables studied in between sub groups of the study.

Parameter

Group 1 Vs Group 2

Group 1 Vs Group 3

Group 2 Vs Group 3

BMI (Kg/m2)

0.001**

0.001**

0.004**

FBS (Mg/dl)

0.001**

0.001**

0.001**

PPBS (Mg/dl)

0.001**

0.001**

0.001**

S. Urea (Mg/dl)

0.92

0.001**

0.001**

S. Creatinine(Mg/dl)

0.86

0.001**

0.001**

S. Uric Acid(Mg/dl)

0.81

0.001**

0.001**

Microalbumin (Mg/g creatinine)

0.94

0.001**

0.001**

U. Nephrin (ng/mL)

0.001**

0.001**

0.001**

In Table 3 represents the comparison of biochemical variables studied between the groups by using post hoc analysis. The BMI, FBS, PPBS, urinary nephrin showed a high significant(P =0.001**) and the urea, creatinine, uric acid and microalbumin not shown any significant (P = 0.92,0.86, 0.81 and 0.94) observed between group 1 and group 2. We observed there was highly significant of BMI, fasting blood sugars, post parandial blood sugars, urea, creatinine, uric acid and urinary nephrin between group 1 vs group 3 and group 2 vs group 3 (P=0.001**).

Table 4

Correlation of anthropometric, demographic, biochemical parameters with urinary nephrin among the study subjects.

Parameter

Urinary Nephrin (ng/ml)

r- Value

P – Values

Age ( Y)

0.096

0.36

Height (CM)

0.298

0.04

Weight (Kg)

0.857

0.001**

BMI (Kg/m2)

0.867

0.001**

FBS (Mg/dl)

0.943

0.001**

PPBS (Mg/dl)

0.944

0.001**

S. Urea (Mg/dl)

0.829

0.001**

S. Creatinine (Mg/dl)

0.826

0.001**

S. Uric Acid (Mg/dl)

0.804

0.001**

Microalbumin (Mg/g creatinine)

0.804

0.001**

Table 4 shows the correlation of anthropometric, demographic, biochemical parameters with urinary nephrin among the study subjects. The urinary nephrin was highly significant positively correlatedand with weight, BMI, fasting blood sugars, post parandial blood sugars, urea, creatinine, uric acid, microalbumin ( P = 0.001**) and moderate significant positive correlation with height (P=0.04*). The nephrin is not correlated with age (P=0.366).

Figure 1

Shows the microalbumin was significantly increased in type 2 diabetes with microalbuminuria than type 2 diabetes with normoalbuminuria and healthy controls.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/020fbf06-7b20-4c67-ad82-c05c0a59ef04image1.png

Figure 2

Shows the significantly and drastically elevated concentrations of refrain in type 2 diabetes with normo, micro than healthy controls.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/020fbf06-7b20-4c67-ad82-c05c0a59ef04image2.png

Figure 3

Shows the scatter plots revealed that there was a positive association between nephrin and microalbumin between the groups.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/020fbf06-7b20-4c67-ad82-c05c0a59ef04image3.png

Discussion

Recently diabetic nephropathy is most common complication associated with type 2 diabetes mellitus, the metabolic derangements in T2DM patients leads to damage of kidney particularly podocytes. 20 Podocytes are very essential components of glomerulus of kidney and it will maintain the slit diaphragm allow the leakage of water and small molecules by podocyte proteins. 21 Nephrin is one of the podocyte protein very important for maintenance of foot process of podocytes and forms the calyx of glomerulus prevent the excretion of protein in urine. 22

In T2DM patients with hyperglycemia and dyslipidaemia leads to production of excess free radicals lead to damage of podocytes. In starting stage of kidney damage plasma protein cannot be excreted due to its size and simultaneously podocyte protein nephrin will be excreted since its having less size lead to nephrinuria. 23, 24 The nephrinuria in patients with T2DM patients with normoalbuminuria without microalbumin can be used as early predectible marker for kidney damage in type 2 diabetic patients.

Present study found the highly significant increased levels of nephrin in the type 2 diabetic subjects with normo and microalbuminuria than in healthy controls (P = 0.001**).

T2DM patients with normoalbuminuria shown significant high concentrations of nephrin without change ofmicroalbumin levels. Similarly other recent studies also reported thetype 2 diabetes with normoalbuminuria shown nephrinuria and there were no change in microalbumin levels. 25 Along with that significantly increased levels of urinary nephrin elevated levels of urinary nephrin has capable to predict early nephropathy in T2DM than microalbumin. Another case control study reported that nephrinuria can be used detection and progression of podocyte damage, kidney injury and diabetic nephropathy. 26

Additionally we observed there was a significant positive correlation between nephrin and fasting blood sugars, post prandial bold sugars, blood urea, creatinine, uric acid, microalbumin and glycated hemoglobin. Previous study also reported that expression of specific protein particularly nephrin positively correlated with albuminuria and can be used as a pre clinical biomarker for diabetic nephropathy.27 Another case control study also reported nephrin positively correlated with microalbumin have consider early predict and prognosticmarker for diabetic nephropathy. 28 Additionally the present study also observed scatter plots revealed the significant nephrinuria and positively correlated with microalbumin might be used as early predectible marker for diabetic nephropathy.

Conclusion

Based on our findings we suggest significantly and drastically elevated concentrations of nephrin in type 2 diabetes with normo and microalbuminuria used as early predectible and prognostic marker for nephropathy.

Source of Funding

None.

Conflict of Interest

None.

References

1 

M Stumvoll BJ Goldstein TW Van Haften Type 2 diabetes: Principles of pathogenesis and therapyLancet2005365946713336

2 

K Huang Y Liang Y Ma J Wu H Luo B Yicorresponding The Variation and Correlation of Serum Adiponectin, Nesfatin-1, IL-6, and TNF-a Levels in PrediabetesFront Endocrinol (Lausanne)20221377427210.3389/fendo.2022.774272

3 

R Pradeepa V Mohan Epidemiology of type 2 diabetes in indiaIndian J Ophthalmol2021691129328

4 

F Alebachew B Belete A Molla Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar HospitalDiabetes Metab Syndr Obes2019127583

5 

Nephropathy in Diabetes. American Diabetes Association. Diabetes CareDiabetes Care 20042717983

6 

B Satirapoj SG Adler Comprehensive approach to diabetic nephropathyKidney Res Clin Pract201433312131

7 

B Satirapoj SG Adler Prevalence and management of diabetic nephropathy in western countries”Kidney Dis (Basel)2015116170

8 

MM Pedersen JS Christiansen EB Pedersen CE Mogensen Determinants of intra-individual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycaemic controlClin Sci199283444551

9 

S Gehan N Nashwa T Almokadem S Mohamed Urinary biomarker N-acetyl- β-D-glucosaminidase can predict severity of renal damage in diabetic nephropathyJ Diabetes Metab Disord201514410.1186/s40200-015-0133-6

10 

GC Carole O Sanchez-Ferras SN Batchu Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic NephropathyCan J Kidney Health Dis20174205435811770537110.1177/2054358117705371

11 

V Ganesh V Shantharam R Raghavendra Study of diabetic foot patients with correlation of blood sugar levels in Bengaluru rural districtMedPulse Int J Biochem202118114

12 

P Ligia A Vlad G Gluhovschi F Gadalean V Dumitrascu C Gluhovschi Proximal tubule dysfunction is associated with podocyte damage biomarkers nephrin and vascular endothelial growth factor in type 2 diabetes mellitus patients: a cross-sectional studyPloS One2014911e11253810.1371/journal.pone.0112538

13 

GKV Goud V Ganesh SP Palem P Study of Serum Adiponectin and Oxidative Stress Levels in Patients With Type 2 Diabetes MellitusBiochemInd J2021151142

14 

B Jim M Ghanta A Qipo Y Fan PY Chuang W Hillel Dysregulated Nephrin in Diabetic Nephropathy of Type 2 Diabetes: A Cross Sectional StudyPLoS One201275360410.1371/journal.pone.0036041

15 

V Ganesh M Murugan Prasad Siva Palem Serum Adiponectin as a Diagnostic Marker of Nephropathy among Patients with Type 2 Diabetes Mellitus: A Cross-sectional StudyJ Clin Diagn Res20221611105

16 

KL Heathcote MP Wilson DW Quest TW Wilson Prevalence and duration of exercise induced albuminuria inhealthy peopleClin Invest Med20093242615

17 

SL Hogan S Vupputuri X Guo J Cai RE Colindres G Heiss Association of cigarette smoking with albuminuria in the United States: the third National Health and Nutrition Examination SurveyRen Fail200729213342

18 

V Ganesh M Murugan SP Palem Adiponectin can be an early predectible marker for type 2 diabetes mellitus and nephropathyCureus2022147e2730810.7759/cureus.27308

19 

American Diabetes Association. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018Diabetes Care201841111134

20 

P O-Charoen LMA Gangcuangco DC Chow LC Ndhlovu JD Barbour CM Shikuma Inflammation and albuminuria inHIV-infected patients receiving combination antiretroviraltherapyHawaii J Med Public Health2014739 Suppl 137

21 

JH An YM Cho HG Yu HC Jang KS Park KS Park The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complicationJ Korean Med Sci20092417581

22 

T Ninomiya V Perkovic BE De Galan S Zoungas A Pillai M Jardine Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetesJ Am Soc Nephrol2009208181321

23 

SN Uwaezuoke The role of novel biomarkers in predicting diabetic nephropathy: a reviewInt J Nephrol Renovasc Dis2017102213110.2147/IJNRD.S143186

24 

Y Okamoto S Kihara T Funahashi Y Matsuzawa P Libby Adiponectin: a key adipocytokine in metabolic syndromeClin Sci (Lond)200611026778

25 

D Mahmood R Alshawk I al-karawi Urinary nephrin and urinary mcp-1 biomarkers predicts the progression of diabetic nephropathy in type 2 diabetic patientInt J Bio-Sci Bio-Technol2017621917

26 

V Ganesh M Murugan VG Goud VK Gangannagari Correlation of urinary nephrin with albuminuria to predict early onset of nephropathy in patients with type 2 diabetes mellitusInt J Health Sci20226S3462130

27 

Y Arita S Kihara N Ouchi K Maeda H Kuriyama Y Okamoto Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-66binding protein and regulates growth factor-induced common post reseptor signal in vascular smooth muscle cellCirculation20021052428938

28 

V Ganesh M Murugan Urinary nephrin is a sensitive marker to predict early onset of nephropathy in type 2 diabetes mellitusJ Lab Physicians2022144494504



jats-html.xsl

© 2024 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)